A Preliminary Study on the Effects of Tartary Buckwheat-derived Nanoparticles on the Physiology of C57BL/6 Mice

ZHANG Jiyue; REN Chaoqin; CAO Yanan; REN Yuanhang; PENG Lianxin

doi:10.13386/j.issn1002-0306.2024060055

Volume 46 Issue 11

May 2025

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2025 > 46(11): 329-337. > DOI: 10.13386/j.issn1002-0306.2024060055

ZHANG Jiyue, REN Chaoqin, CAO Yanan, et al. A Preliminary Study on the Effects of Tartary Buckwheat-derived Nanoparticles on the Physiology of C57BL/6 Mice[J]. Science and Technology of Food Industry, 2025, 46(11): 329−337. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024060055.

Citation:

PDF (4576 KB)

A Preliminary Study on the Effects of Tartary Buckwheat-derived Nanoparticles on the Physiology of C57BL/6 Mice

ZHANG Jiyue^{1, 2,},
REN Chaoqin³,
CAO Yanan^{1, 2},
REN Yuanhang^{1, 2},
PENG Lianxin^{1, 2, ,}

1.
Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and Rural Affairs, Chengdu University, Chengdu 610106, China
2.
Sichuan Province Engineering Technology Research Center of Coarse Cereal Industralization, Chengdu 610106, China
3.
School of Resources and Environment, Aba Normal University, Aba Prefecture 623002, China

More Information

Received Date: June 05, 2024
Available Online: March 25, 2025

Graphical Abstract

Abstract

Abstract

Objective: To investigate the effects of dietary supplementation with tartary buckwheat-derived nanoparticles (TBDNs) on key physiological parameters in mice. Methods: Twenty-four C57BL/6 mice were randomly assigned to two groups: a normal control group and a TBDNs group. Changes in body weight, blood biochemical markers, cell histology and immunohistochemistry of the colon and liver, as well as intestinal flora composition, were analyzed. Results: Compared to the normal diet group, the 10 mg TBDNs group exhibited significant reductions in body weight, triglyceride levels, uric acid levels, and alanine aminotransferase activity (P<0.01). Physiological indicators such as aspartate aminotransferase, cholesterol, high-density lipoprotein, low-density lipoprotein, and creatinine, as well as liver and colon tissues, showed no significant changes (P>0.05). The abundance of intestinal Lactobacillus, Turicibacter, and Lachnoclostridium species were all significant increased (P<0.05). Conclusion: Intake of TBDNs has discernible physiological effects on mice, however, further investigations are required to elucidate its underlying mechanisms and potential health benefits. These findings provide novel insights and data for nutritional evaluation of tartary buckwheat.
- tartary buckwheat,
- tartary buckwheat-derived nanoparticles,
- gut microbiota,
- nutrition and health

FullText(HTML)

References (47)

References

[1]	彭镰心. 基于调节糖脂代谢效应的苦荞资源品质研究[D]. 成都:成都中医药大学, 2019. [PENG Lianxin. Study on the quality of tartary buckwheat resources based on the effect of regulating glucolipid metabolism[D]. Chengdu:Chengdu University of Traditional Chinese Medicine, 2019.] PENG Lianxin. Study on the quality of tartary buckwheat resources based on the effect of regulating glucolipid metabolism[D]. Chengdu: Chengdu University of Traditional Chinese Medicine, 2019.
[2]	刘钰. 苦荞来源的纳米颗粒对肠道微生物的影响及发酵饮料的研发[D]. 成都:成都大学, 2022. [LIU Yu. Effect of tartary buckwheat-derived nanoparticles (TBDNs) on gut microbiota and development of fermented beverages[D]. Chengdu:Chengdu University, 2022.] LIU Yu. Effect of tartary buckwheat-derived nanoparticles （TBDNs） on gut microbiota and development of fermented beverages[D]. Chengdu: Chengdu University, 2022.
[3]	ZOU L, WU D, REN G, et al. Bioactive compounds, health benefits, and industrial applications of tartary buckwheat (Fagopyrum tataricum)[J]. Critical Reviews in Food Science and Nutrition,2023,63(5):657−673. doi: 10.1080/10408398.2021.1952161
[4]	STEWART L K, WANG Z, RIBNICKY D, et al. Failure of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity[J]. Diabetologia,2009,52(3):514−523. doi: 10.1007/s00125-008-1252-0
[5]	JU S, MU J, DOKLAND T, et al. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis[J]. Molecular Therapy,2013,21(7):1345−1357. doi: 10.1038/mt.2013.64
[6]	PÉREZ-BERMÚDEZ P, BLESA J, SORIANO J M, et al. Extracellular vesicles in food:Experimental evidence of their secretion in grape fruits[J]. European Journal of Pharmaceutical Sciences,2017,98:40−50. doi: 10.1016/j.ejps.2016.09.022
[7]	MU J, ZHUANG X, WANG Q, et al. Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles[J]. Molecular Nutrition & Food Research,2014,58(7):1561−1573.
[8]	ZHANG M, VIENNOIS E, PRASAD M, et al. Edible ginger-derived nanoparticles:A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer[J]. Biomaterials,2016,101:321−340. doi: 10.1016/j.biomaterials.2016.06.018
[9]	MAN F, MENG C, LIU Y, et al. The study of ginger-derived extracellular vesicles as a natural nanoscale drug carrier and their intestinal absorption in rats[J]. AAPS PharmSciTech,2021,22(6):206. doi: 10.1208/s12249-021-02087-7
[10]	BERGER E, COLOSETTI P, JALABERT A, et al. Use of nanovesicles from orange juice to reverse diet-induced gut modifications in diet-induced obese mice[J]. Molecular Therapy Methods & Clinical Development,2020,18:880−892.
[11]	赵婉均. 蓝莓外泌体样纳米颗粒对肥胖小鼠肝细胞氧化应激的调节作用及机制研究[D]. 重庆:重庆理工大学, 2021. [ZHAO Wanjun. Blueberry-derived exosomes-like nanoparticles antagonize oxidative stress and its associated molecular mechanisms in the hepatocytes of HFD-fed mice[D]. Chongqing:Chongqing University of Technology, 2021.] ZHAO Wanjun. Blueberry-derived exosomes-like nanoparticles antagonize oxidative stress and its associated molecular mechanisms in the hepatocytes of HFD-fed mice[D]. Chongqing: Chongqing University of Technology, 2021.
[12]	LIU Y, REN C, ZHAN R, et al. Exploring the potential of plant-derived exosome-like nanovesicle as functional food components for human health:A review[J]. Foods,2024,13(5):712. doi: 10.3390/foods13050712
[13]	LIU Y, TAN M L, ZHU W J, et al. In vitro effects of tartary buckwheat-derived nanovesicles on gut microbiota[J]. Journal of Agricultural and Food Chemistry,2022,70(8):2616−2629. doi: 10.1021/acs.jafc.1c07658
[14]	SURESH A P, KALARIKKAL S P, PULLAREDDY B, et al. Low pH-based method to increase the yield of plant-derived nanoparticles from fresh ginger rhizomes[J]. ACS Omega,2021,6(27):17635−17641. doi: 10.1021/acsomega.1c02162
[15]	李琰. 白藜芦醇通过调节肠道菌群和下调PPAR信号通路治疗酒精性脂肪肝的机制研究[D]. 辽宁:中国医科大学, 2022. [LI Yan. Study on the mechanism of resveratrol in the treatment of alcoholic fatty liver in mice by regulating gut microbiota and down regulating PPAR signaling pathway[D]. Liaoning:China Medical University, 2022.] LI Yan. Study on the mechanism of resveratrol in the treatment of alcoholic fatty liver in mice by regulating gut microbiota and down regulating PPAR signaling pathway[D]. Liaoning: China Medical University, 2022.
[16]	PENG L, ZHANG Q, ZHANG Y, et al. Effect of tartary buckwheat, rutin, and quercetin on lipid metabolism in rats during high dietary fat intake[J]. Food Science & Nutrition,2020,8(1):199−213.
[17]	董志忠. 全谷物类产品的营养健康意义及产业发展机会[C]//粮食食品与营养健康产业发展科技论坛暨行业发展峰会, 2016. [DONG Zhizhong. The nutritional health significance and industrial development opportunities of whole grain products[C]//Conference on Grain Food and Nutritional Health Industry Development Technology Forum and Industry Development Summit, 2016.] DONG Zhizhong. The nutritional health significance and industrial development opportunities of whole grain products[C]//Conference on Grain Food and Nutritional Health Industry Development Technology Forum and Industry Development Summit, 2016.
[18]	KONG C, YAN X, LIU Y, et al. Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome[J]. Signal Transduction and Targeted Therapy,2021,6(1):154. doi: 10.1038/s41392-021-00549-9
[19]	XIE Z, XIE T, LIU J, et al. Glucokinase inactivation ameliorates lipid accumulation and exerts favorable effects on lipid metabolism in hepatocytes[J]. International Journal of Molecular Sciences,2023,24(5):4315. doi: 10.3390/ijms24054315
[20]	LU F, LI Y, WANG X, et al. Early-life polyphenol intake promotes Akkermansia growth and increase of host goblet cells in association with the potential synergistic effect of Lactobacillus[J]. Food Research International (Ottawa, Ont),2021,149:110648. doi: 10.1016/j.foodres.2021.110648
[21]	BORGONOVI T F, VIRGOLIN L B, JANZANTTI N S, et al. Fruit bioactive compounds:Effect on lactic acid bacteria and on intestinal microbiota[J]. Food Research International (Ottawa, Ont),2022,161:111809. doi: 10.1016/j.foodres.2022.111809
[22]	MIAO J, CUI H T, WANG L, et al. Effects of evodiamine on carbon tetrachloride-induced liver fibrosis mice based on modulating gut microbiota[J]. Chinese Journal of Industrial Hygiene and Occupational Diseases,2021,39(6):401−406.
[23]	PENG M, WANG L, SU H, et al. Ginsenoside Rg1 improved diabetes through regulating the intestinal microbiota in high-fat diet and streptozotocin-induced type 2 diabetes rats[J]. Journal of Food Biochemistry,2022,46(10):e14321.
[24]	CAI Y Y, HUANG F Q, LAO X, et al. Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis[J]. NPJ Biofilms and Microbiomes,2022,8(1):11. doi: 10.1038/s41522-022-00273-4
[25]	WANG G, ZHANG Y, ZHANG R, et al. The protective effects of walnut green husk polysaccharide on liver injury, vascular endothelial dysfunction and disorder of gut microbiota in high fructose-induced mice[J]. International Journal of Biological Macromolecules,2020,162:92−106. doi: 10.1016/j.ijbiomac.2020.06.055
[26]	LLOYD-PRICE J, ARZE C, ANANTHAKRISHNAN A N, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases[J]. Nature,2019,569(7758):655−662. doi: 10.1038/s41586-019-1237-9
[27]	ZHENG H, LIANG H, WANG Y, et al. Altered gut microbiota composition associated with eczema in infants[J]. PloS One,2016,11(11):e0166026. doi: 10.1371/journal.pone.0166026
[28]	AZZOUZ D, OMARBEKOVA A, HEGUY A, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal[J]. Annals of the Rheumatic Diseases,2019,78(7):947−956. doi: 10.1136/annrheumdis-2018-214856
[29]	BREBAN M, TAP J, LEBOIME A, et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis[J]. Annals of the Rheumatic Diseases,2017,76(9):1614−1622. doi: 10.1136/annrheumdis-2016-211064
[30]	CHUA H H, CHOU H C, TUNG Y L, et al. Intestinal dysbiosis featuring abundance of Ruminococcus gnavus associates with allergic diseases in infants[J]. Gastroenterology,2018,154(1):154−167. doi: 10.1053/j.gastro.2017.09.006
[31]	HUANG C, LI Y, FENG X, et al. Distinct gut microbiota composition and functional category in children with cerebral palsy and epilepsy[J]. Frontiers in Pediatrics,2019,7:394. doi: 10.3389/fped.2019.00394
[32]	GRAHNEMO L, NETHANDER M, COWARD E, et al. Cross-sectional associations between the gut microbe Ruminococcus gnavus and features of the metabolic syndrome[J]. The lancet Diabetes & Endocrinology,2022,10(7):481−483.
[33]	LUKIĆ I, GETSELTER D, ZIV O, et al. Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior[J]. Translational Osychiatry,2019,9(1):133. doi: 10.1038/s41398-019-0466-x
[34]	WANG L, CHRISTOPHERSEN C T, SORICH M J, et al. Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder[J]. Molecular Autism,2013,4(1):42. doi: 10.1186/2040-2392-4-42
[35]	HENKE M T, KENNY D J, CASSILLY C D, et al. Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide[J]. Proceedings of the National Academy of Sciences of the United States of America,2019,116(26):12672−12677.
[36]	MURUGESAN S, ULLOA-MARTÍNEZ M, MARTÍNEZ-ROJANO H, et al. Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children[J]. European Journal of Clinical Microbiology and Infectious Diseases,2015,34(7):1337−1346. doi: 10.1007/s10096-015-2355-4
[37]	VERDAM F J, FUENTES S, de JONGE C, et al. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity[J]. Obesity (Silver Spring, Md),2013,21(12):E607−15.
[38]	KASAI C, SUGIMOTO K, MORITANI I, et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing[J]. BMC Gastroenterology,2015,15:100. doi: 10.1186/s12876-015-0330-2
[39]	刘巧红, 赵瑜, 胡义扬. 饮食对非酒精性脂肪性肝病肠道微生物菌型相关菌群的影响[J]. 临床肝胆病杂志,2021,37(4):4. [LIU Q H, ZHAO Y, HU Y Y. Effect of diet on enterotype-related gut microbiota in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatol,2021,37(4):4.] doi: 10.3969/j.issn.1001-5256.2021.04.046 LIU Q H, ZHAO Y, HU Y Y. Effect of diet on enterotype-related gut microbiota in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatol, 2021, 37（4）: 4. doi: 10.3969/j.issn.1001-5256.2021.04.046
[40]	KULATHUNGA J, SIMSEK S. A review:Cereals on modulating the microbiota/metabolome for metabolic health[J]. Current Nutrition Reports,2022,11(3):371−385. doi: 10.1007/s13668-022-00424-1
[41]	MARCELINO G, HIANE P A, FREITAS K C, et al. Effects of olive oil and its minor components on cardiovascular diseases, inflammation, and gut microbiota[J]. Nutrients,2019,11(8):1826. doi: 10.3390/nu11081826
[42]	TORAL M, ROBLES-VERA I, de LA VISITACIÓN N, et al. Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats[J]. Acta Physiologica (Oxford, England),2019,227(1):e13285. doi: 10.1111/apha.13285
[43]	ZHANG L, OUYANG Y, LI H, et al. Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects:A randomized crossover trial[J]. Scientific Reports,2019,9(1):4736. doi: 10.1038/s41598-018-38216-9
[44]	STOJANOV S, BERLEC A, ŠTRUKELJ B. The influence of probiotics on the Firmicutes/Bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease[J]. Microorganisms,2020,8(11):1715. doi: 10.3390/microorganisms8111715
[45]	ZAFAR H, SAIER M H. Gut Bacteroides species in health and disease[J]. Gut Microbes,2021,13(1):1−20.
[46]	YOSHIDA N, EMOTO T, YAMASHITA T, et al. Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis[J]. Circulation,2018,138(22):2486−2498. doi: 10.1161/CIRCULATIONAHA.118.033714
[47]	CAO Y, WANG Z, YAN Y, et al. Enterotoxigenic Bacteroides fragilis promotes intestinal inflammation and malignancy by inhibiting exosomes-packaged miR-149-3p[J]. Gastroenterology,2021,161(5):1552−1566. doi: 10.1053/j.gastro.2021.08.003